What is the Mu variant, exactly?
The Mu variant was first identified in Colombia in January 2021, according to the WHO. Since that time, there have been some scattered cases, as well as reports of larger outbreaks, around the world, including in other areas of South America, the UK, Europe, the US, and Hong Kong.
As a variant of interest, Mu has “a constellation of mutations that indicate potential properties of immune escape” according to the weekly bulletin from the WHO. In addition, variants of interest are defined as those that have genetic changes that are known to (or are predicted to) affect certain virus characteristics, including disease severity, immune escape, diagnostic or therapeutic escape, and transmissibility, and have been “identified to cause significant community transmission or multiple COVID-19 clusters, in multiple countries with increasing relative prevalence alongside increasing number of cases over time, or other apparent epidemiological impacts to suggest an emerging risk to global public health,” according to the WHO. However, the organization also says more research is needed to fully understand Mu and what it’s capable of.
How worried should you be about the Mu variant?
This particular variant isn’t as widespread at the moment as many other that are listed as “of interest.” According to data from the WHO bulletin, it currently makes up less than 0.1% of COVID-19 infections in the world, though rates are higher in certain countries, including Colombia (where it accounts for 39% of cases) and Ecuador (13%).
Worth noting, however: Mu is currently not on the Centers for Disease Control and Prevention’s list of variants of interest or variants of concern, at least for the time being.
“It’s not very concerning at the present time,” William Schaffner, M.D., an infectious disease specialist and professor at the Vanderbilt University School of Medicine, tells Health. He points out that Mu was first detected in January of this year and is only now being named a variant of interest. “Researchers are still assessing how quickly it spreads and what its level of contagiousness is,” he says. “It’s interesting that it’s even reached the level of becoming a variant of interest [with the WHO].”
Infectious disease expert Amesh A. Adalja, M.D., a senior scholar at the Johns Hopkins Center for Health Security agrees that there’s no reason to panic over Mu at the moment. ” People should not be so worried about this variant,” he tells Health. “Variants are continuously being generated.”
Dr. Adalja also doesn’t think that Mu will overtake the Delta variant. “It’s unlikely that it is more fit than Delta and will be able to overtake it,” he says.
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]